Comparison 13. Subgroup analysis for fluoxetine versus heterocyclics: endpoint score.
Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
---|---|---|---|---|
1 follow‐up <6 weeks | 2 | Std. Mean Difference (IV, Random, 95% CI) | Subtotals only | |
1.1 Fluoxetine vs Maprotiline | 2 | 181 | Std. Mean Difference (IV, Random, 95% CI) | 0.06 [‐0.34, 0.46] |
2 follow‐up 6‐16 weeks | 6 | Std. Mean Difference (IV, Random, 95% CI) | Subtotals only | |
2.1 Fluoxetine vs Maprotiline | 3 | 252 | Std. Mean Difference (IV, Random, 95% CI) | 0.05 [‐0.20, 0.30] |
2.2 Fluoxetine vs Mianserin | 3 | 128 | Std. Mean Difference (IV, Random, 95% CI) | 0.43 [‐0.38, 1.23] |